Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.800
-0.190 (-9.55%)
At close: May 8, 2026, 4:00 PM EDT
1.820
+0.020 (1.11%)
After-hours: May 8, 2026, 7:34 PM EDT
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $301.36 million as of May 8, 2026. Its market cap has increased by 9,586.82% in one year.
Market Cap
301.36M
Enterprise Value
171.40M
1-Year Change
9,586.82%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $301.36M, an increase of 301.45%. That is a compound annual growth rate of 31.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 333.17M | -4.85% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 341.30M |
| Compass Therapeutics | 341.27M |
| Armata Pharmaceuticals | 335.76M |
| Silence Therapeutics | 335.36M |
| Inhibikase Therapeutics | 334.94M |
| Immuneering | 332.54M |
| Rezolute | 328.24M |
| Greenwich LifeSciences | 325.86M |